Risk Minimisation materials for Pradaxa capsules (dabigatran etexilate): Prescriber guides for various indications and Patient Alert Card

The Prescriber guide for primary prevention of venous thromboembolic events following elective hip or knee replacement surgery provides recommendations for orthopaedic use with the aim of minimising risk of bleeding, and providing guidance on how to manage that risk.

Separately, a Prescriber Guide for stroke prevention in non-valvular atrial fibrillation (NVAF) and for the treatment and secondary prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) provides recommendations on minimising the risk of bleeding.

 

Every patient prescribed dabigatran will receive a Patient Alert Card in the medication pack. As the card contains important information the patient should be instructed to carry the patient alert card at all times and present it when seeing a healthcare professional. The patient should be counselled about the need for compliance and signs of bleeding and when to seek medical attention.